VT News
Ramin Karimloo

Ramin Karimloo

Ask VT AI
View News Summary
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
  • Motorola beats Q3 estimates, raises 2025 EPS guidance, and cites robust demand for public-safety and government solutions as key growth drivers.
  • Most areas see acceptable Halloween conditions, but Houston, New England face storms.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
  • Motorola beats Q3 estimates, raises 2025 EPS guidance, and cites robust demand for public-safety and government solutions as key growth drivers.
  • Most areas see acceptable Halloween conditions, but Houston, New England face storms.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Ramin Karimloo

Top Topics

Trending in U.S.

World

Sport